Our group has shown that higher circulating PON1 activity generated by overexpression of the PON1 transgene in an animal model of RA reduces inflammatory arthritis, associating with decreases in 5-HETE and 15 HETE without significant changes in serum cytokine or chemokines [24]. The gene discussed is PON1; the disease is rheumatoid arthritis.